Eszopiclone, marketed under the brand name Lunesta, is a non-benzodiazepine hypnotic agent used for the treatment of insomnia. It is classified as a 'Z-drug' due to its chemical structure and its mechanism of action, which is similar to benzodiazepines but with a distinct chemical composition. Eszopiclone is indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance. It helps individuals fall asleep faster and stay asleep longer, thereby improving overall sleep quality.
Eszopiclone is available as an oral tablet and is typically taken just before bedtime. As a controlled substance in many regions, its use requires a prescription from a licensed healthcare professional. Its efficacy and safety have been established through numerous clinical trials. However, due to its potential for dependence and adverse effects, it is generally recommended for short-term use. Long-term use should be carefully evaluated by a clinician. (FDA label, DrugBank)
Deep dive
Tap a section to expand.
Known interactions
Category rule: supplement × medication
Note
Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).
Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist.
Category rule: vitamin × medication
Note
Certain vitamins interact with specific medications (e.g., vitamin K with blood thinners).
Specific pairs are checked against a licensed source; confirm with your provider.
Compound-pair rule
Note
Additive sedation possible.
Start at low melatonin dose (0.3–1 mg) when combined with prescription sedatives.
Frequently asked
Sources referenced
["U.S. Food and Drug Administration (FDA) label for Lunesta (eszopiclone)", "DrugBank", "MedlinePlus", "Cochrane Library"]
Stackwise compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician.
Related compounds
Others in the medication category or studied for the same goals.